Dental products company Envista Holdings (NYSE:NVST)
will be announcing earnings results tomorrow after market close. Here’s what investors should know.
Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season.
Over the last six months, Envista shares have sunk to $15.51, producing a disappointing 18.5% loss - worse than the S&P 500’s 8.1% drop. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Envista (NYSE:NVST) and the best and worst performers in the dental equipment & technology industry.
Let’s dig into the relative performance of Align Technology (NASDAQ:ALGN) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and worst performers in the dental equipment & technology industry.
Dental products company Envista Holdings (NYSE:NVST) announced better-than-expected revenue in Q4 CY2024, with sales up 1.1% year on year to $652.9 million. Its non-GAAP profit of $0.24 per share was 9.9% above analysts’ consensus estimates.
Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a strong bid unlikely to face competition.
